Health in Slovakia 1,271 indicators covering health for Slovakia. IndicatorLatest Year10-yr change Rank Primary health care expenditure (PHCE) per сapita in US$ 578.44 2020 — 27th Deaths related to infectious diseases 407 2024 up 160.9% 21st Causes of death - infant mortality by country of occurrence 276 2024 down 12.9% 14th Fetal, peri- and neonatal mortality rates by country of occurrence 4 2024 up 33.3% 15th Peri-neonatal mortality by age of mother, country of residence and 185 2024 up 10.8% 19th Reported cases of gonorrhea 458 2023 up 21.2% 21st Reported cases of syphilis 695 2023 up 106.2% 19th Causes of death - potential years of life lost by treatable and 4,867 2023 down 16.9% 8th Treatable and preventable mortality of residents by cause and sex 19,023 2023 down 2.4% 16th Antimicrobial resistance or decreased susceptibiity (DS/R) to 16.3 2022 up 486.3% 20th Antimicrobial resistance or decreased susceptibiity (DS/R) to 80 2022 down 25.9% 36th Causes of death - infant mortality by country of residence 275 2023 down 8.9% 11th Financial hardship in health and components (SDG 3.8.2, 2025) 13.8% 2015 up 32.8% 29th Influenza vaccination rate elderly oecd 12.8 2020 down 46.2% 31st Reported cases of chlamydia 1,037 2023 up 12.8% 20th Excess mortality by month -7.5 2026 down 112.9% 21st Breast cancer screening coverage in europe 28.45 2022 down 10.1% 24th Consumption of antibiotics in the community and hospital sectors 20.4 2024 down 3.8% 15th Number of people spending more than 10% of household consumption or 203,000.0% 2010 down 28.5% 29th Number of people spending more than 25% of household consumption or 24,000.0% 2010 up 4.3% 28th Hospital days of in-patients - historical data 6.13 million 2020 down 19.3% 15th Number of people pushed below the $2.15 ($ 2017 PPP) poverty line by 0 2010 down 100.0% 21st Number of people pushed below the $3.65 ($ 2017 PPP) poverty line by 1,000 2010 — 28th Hospital discharges by diagnosis, in-patients, total number 845,040 2020 down 16.6% 15th Hospital discharges by diagnosis, in-patients, per 100 000 15,480 2020 down 17.3% 7th Cancer screening rates in europe 46.43 2022 down 2.1% 14th Cervical cancer screening coverage in europe 46.43 2022 down 2.1% 14th Infant mortality by mother's educational attainment level (ISCED11f) 274 2024 — 12th Imports in 1000s hectolitres 816 2007 up 35.5% 2nd Population with household spending on health greater than 25% of 0.5% 2010 up 62.1% 38th Hospital discharges by diagnosis, day cases, total number 20,168 2020 down 32.4% 21st Population pushed below a relative poverty line by household health 0.5% 2010 down 75.0% 39th Increase in poverty gap due to household health expenditures 0.2% 2010 down 26.5% 35th Number of isolates tested for ceftriaxone 108 2020 up 22.7% 28th Proportion of isolates with decreased susceptibility or resistance 0 2020 — 13th Hospital discharges by diagnosis, day cases, per 100 000 inhabitants 369.5 2020 down 33.0% 22nd Population pushed below the $3.20 a day poverty line by household 0.0% 2010 down 100.0% 35th Increase in poverty gap due to household health expenditures 0.0% 2010 down 100.0% 35th Increase in poverty gap due to household health expenditures 0.0% 2010 down 100.0% 35th Population pushed below the $1.90 a day poverty line by household 0.0% 2010 down 100.0% 28th Increase in poverty gap due to household health expenditures 0.0% 2010 — 26th Population pushed below the $2.15 a day poverty line by household 0.0% 2010 — 26th Increase in poverty gap due to household health expenditures 0.0% 2010 — 25th Population pushed further below the $3.20 a day poverty line by 0.0% 2010 down 98.6% 36th Population pushed below the $3.65 a day poverty line by household 0.0% 2010 down 100.0% 34th Population pushed further below the $3.65 a day poverty line by 0.0% 2010 down 96.6% 35th Proportion of isolates with resistance to azithromycin reported to 2.8 2020 down 90.5% 35th Number of isolates tested for azithromycin 108 2020 up 22.7% 27th Households with out-of-pocket payments greater than 40% of capacity 5.1% 2015 up 4.8% 18th Proportion of isolates with resistance to ciprofloxacin reported to 35.1 2018 down 64.9% 47th Number of isolates tested for ciprofloxacin 77 2018 up 413.3% 36th 4.1.1 Proportion of children and young people at the end of lower 74.91 2018 down 5.1% 28th Proportion of isolates with decreased susceptibility or resistance 0 2018 — 25th Number of isolates tested for extended-spectrum cephalosporins 77 2018 up 413.3% 36th Population with household spending on health greater than 10% of 7.1% 2015 down 33.9% 17th Population pushed further below a relative poverty line by household 10.9% 2015 up 67.4% 15th 4.1.1 Proportion of children and young people at the end of lower 68.59 2018 down 11.8% 36th Proportion of children at the end of lower secondary achieving at 72.3% 2015 down 8.6% 33rd Exports of beer (barley) in 1000s hectolitres 37 2009 down 68.6% 46th Proportion of isolates with decreased susceptibility or resistance 0 2018 — 15th ← Previous Page 21 of 22 Next →